Experience

Demy-Colton

• United States
• Events Services
• 1 - 100 Employee

• Founder & CEO

  • Apr 2008 - Present

  New York Area Sara is one of the most influential networkers and connectors in the life sciences industry. As the CEO & Founder of Demy-Colton, a leading life sciences events organizer, she brings more than 22 years of experience launching, developing, and shaping high-profile investor and business development conferences in the healthcare industry. In 2008, Sara founded Demy-Colton, a company dedicated to facilitating growth in life sciences and digital medicine, through the creation of compelling… Show more Sara is one of the most influential networkers and connectors in the life sciences industry. As the CEO & Founder of Demy-Colton, a leading life sciences events organizer, she brings more than 22 years of experience launching, developing, and shaping high-profile investor and business development conferences in the healthcare industry. In 2008, Sara founded Demy-Colton, a company dedicated to facilitating growth in life sciences and digital medicine, through the creation of compelling industry conferences and virtual events. She is committed to fostering the support and advancement of entrepreneurs and companies that are focused on bringing innovative new therapies to improve patient lives and care. Sara is a fierce advocate for diversity in all forms and has made a commitment to fostering inclusion in all Demy-Colton events, both in-person and virtual. As one of the founders of Biotech Showcase, she led the movement on calling out “manels,” and made a commitment to ensure gender diversity on all panels, at all events. Prior to founding Demy-Colton, Sara was Vice President for Business Development and Investor Relations at the Biotechnology Innovation Organization (BIO). During her tenure, she led the launch of the BIO CEO & Investor Conference, BIO Investor Forum, BIO Asia, regional investor forums, the Business Forum at BIO’s annual meeting. She expanded BIO-Europe, helped launch BioEurope Spring, and BioEquity, and developed the partnering system that is now an important component of all biopharma business development meetings. She holds a BA in International Relations from the University at Albany. Show less



The Life Sciences Report

• Advisor

  • 2011 - 2016

  Petaluma, CA Investors rely on the Life Sciences Report, produced by Streetwise Reports, to share promising investment ideas in an evolving industry. Its exclusive interviews with leading industry experts and analysts provide investors with insight and strategies that will help them capitalize on developing trends. This valuable tool aggregates their exclusive interviews with in-depth company information, summaries from the latest research reports and company news and amplifies it to a global audience of… Show more Investors rely on the Life Sciences Report, produced by Streetwise Reports, to share promising investment ideas in an evolving industry. Its exclusive interviews with leading industry experts and analysts provide investors with insight and strategies that will help them capitalize on developing trends. This valuable tool aggregates their exclusive interviews with in-depth company information, summaries from the latest research reports and company news and amplifies it to a global audience of institutional and retail investors. Show less



Biotechnology Innovation Organization

• United States
• Biotechnology Research
• 300 - 400 Employee

• Vice President, Business Development & Investor Relations

  • Sep 1998 - Mar 2008

  New York, New York, United States Sara served as Vice President for Business Development & Investor Relations and head of the New York Office. In addition to being a senior representative of BIO to the business and financial community, Sara was responsible for building a portfolio of dynamic and cutting-edge programs designed to help biotech companies raise capital and form strategic partnerships. In 2007 alone, these programs delivered high-value added services to more than 15,000 indivduals representing 5500 companies… Show more Sara served as Vice President for Business Development & Investor Relations and head of the New York Office. In addition to being a senior representative of BIO to the business and financial community, Sara was responsible for building a portfolio of dynamic and cutting-edge programs designed to help biotech companies raise capital and form strategic partnerships. In 2007 alone, these programs delivered high-value added services to more than 15,000 indivduals representing 5500 companies worldwide. Sara's network contacts in the biopharmaceutical industry is extensive.

• Consultant

  • Feb 1998 - Sep 1998

  Sara worked with BIO to launch the Investor program at BIO 1998 which was held in New York City.



Empire State Development Corporation

• Director, Foreign Investment

  • 1976 - 1998

  Sara was responsible for marketing New York as a location of choice for companies headquartered outside of the US , leading the project teams to identify a location, and then execute on the financial packaging, coordination of federal, state, and local government services and any other support the company needed. Marketing New York involved a number of different tactics. The first was to research and identify companies that were in a position to move to the US and then preparing an… Show more Sara was responsible for marketing New York as a location of choice for companies headquartered outside of the US , leading the project teams to identify a location, and then execute on the financial packaging, coordination of federal, state, and local government services and any other support the company needed. Marketing New York involved a number of different tactics. The first was to research and identify companies that were in a position to move to the US and then preparing an offer that included potential locations, financing options, coordination with any regulatory agencies, and organizing a professional team to execute the project. It also included organizing and executing numerous road trips to present these options to management throughout Europe. Show less